Summary
Antimicrobial Hydrogel Dressings Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Summary
Medical Devices sector report, “Antimicrobial Hydrogel Dressings Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Antimicrobial Hydrogel Dressings pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
These are hydrogel dressings impregnated with an agent that inhibits microbial growth.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Antimicrobial Hydrogel Dressings under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Antimicrobial Hydrogel Dressings and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Antimicrobial Hydrogel Dressings under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Antimicrobial Hydrogel Dressings Overview
3 Products under Development
3.1 Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
3.2 Antimicrobial Hydrogel Dressings - Pipeline Products by Territory
3.3 Antimicrobial Hydrogel Dressings - Pipeline Products by Regulatory Path
3.4 Antimicrobial Hydrogel Dressings - Pipeline Products by Estimated Approval Date
3.5 Antimicrobial Hydrogel Dressings - Ongoing Clinical Trials
4 Antimicrobial Hydrogel Dressings - Pipeline Products under Development by Companies
4.1 Antimicrobial Hydrogel Dressings Companies - Pipeline Products by Stage of Development
4.2 Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
5 Antimicrobial Hydrogel Dressings Companies and Product Overview
5.1 CelaCare Technologies LLC Company Overview
5.2 Edixomed Ltd Company Overview
5.3 Gel4Med Inc Company Overview
5.4 In2cure AB Company Overview
5.5 Institute of Nano Science and Technology Company Overview
5.6 Kane Biotech Inc Company Overview
5.7 Novyx Technologies LLC Company Overview
5.8 O2 Regentech LLC Company Overview
5.9 Plurogen Therapeutics Inc Company Overview
5.10 Quick-Med Technologies Inc Company Overview
5.11 Smith & Nephew Plc Company Overview
5.12 Syracuse University Company Overview
6 Antimicrobial Hydrogel Dressings- Recent Developments
6.1 Sep 28, 2022: Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto
6.2 Sep 26, 2022: Covalon to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting
6.3 Aug 29, 2022: Covalon Announces Third Quarter Fiscal 2022 Results
6.4 Aug 01, 2022: Advanced Medical Solutions Group Announce Directorate Change
6.5 Jul 13, 2022: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results
6.6 Jun 08, 2022: Advanced Medical Solutions Grp Annual General Meeting
6.7 Apr 28, 2022: Smith+Nephew First Quarter 2022 Trading Update
6.8 Mar 31, 2022: Smith & Nephew announces Directorate Change
6.9 Mar 07, 2022: Smith & Nephew Announces Notice of Annual General Meeting
6.10 Mar 07, 2022: Smith & Nephew Notice of 85th Annual General Meeting
6.11 Feb 22, 2022: Smith+nephew Announces New Chief Executive Officer
6.12 Dec 13, 2021: Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Tables
Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
Antimicrobial Hydrogel Dressings - Pipeline Products by Territory
Antimicrobial Hydrogel Dressings - Pipeline Products by Regulatory Path
Antimicrobial Hydrogel Dressings - Pipeline Products by Estimated Approval Date
Antimicrobial Hydrogel Dressings - Ongoing Clinical Trials
Antimicrobial Hydrogel Dressings Companies - Pipeline Products by Stage of Development
Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
CelaCare Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
OTC Antimicrobial Gel - Product Status
OTC Antimicrobial Gel - Product Description
Prescription Gel 1 - Product Status
Prescription Gel 1 - Product Description
Prescription Gel 2 - Product Status
Prescription Gel 2 - Product Description
Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
EDX110 - Burns - Product Status
EDX110 - Burns - Product Description
EDX110 - Cystic Fibrosis - Product Status
EDX110 - Cystic Fibrosis - Product Description
EDX110 - Diabetic Foot Ulcer - Product Status
EDX110 - Diabetic Foot Ulcer - Product Description
EDX110 - Pressure Ulcers - Product Status
EDX110 - Pressure Ulcers - Product Description
EDX110 - Septic Shock - Product Status
EDX110 - Septic Shock - Product Description
EDX110 - Surgical Wounds - Product Status
EDX110 - Surgical Wounds - Product Description
EDX110 - Venous Leg Ulcers - Product Status
EDX110 - Venous Leg Ulcers - Product Description
Gel4Med Inc Pipeline Products & Ongoing Clinical Trials Overview
G4db - Product Status
G4db - Product Description
G4I - Product Status
G4I - Product Description
In2cure AB Pipeline Products & Ongoing Clinical Trials Overview
TCP-25 - Product Status
TCP-25 - Product Description
In2cure AB - Ongoing Clinical Trials Overview
TCP-25 - A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Male and Female Volunteers to Investigate the Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds
Institute of Nano Science and Technology Pipeline Products & Ongoing Clinical Trials Overview
Smart Injectable Hydrogel - Product Status
Smart Injectable Hydrogel - Product Description
Kane Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Coactiv+ Antimicrobial Hydrogel - Product Status
Coactiv+ Antimicrobial Hydrogel - Product Description
Novyx Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Hydrogel Wound Dressing - Product Status
Hydrogel Wound Dressing - Product Description
O2 Regentech LLC Pipeline Products & Ongoing Clinical Trials Overview
OXAID - Product Status
OXAID - Product Description
Plurogen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
PluroGel PNN - Product Status
PluroGel PNN - Product Description
Plurogen Therapeutics Inc - Ongoing Clinical Trials Overview
PluroGel PNN - A Between Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries
PluroGel PNN - A Within Patient, Pilot Randomized Controlled Study of Plurogel Compared to Standard Topical Dressing in Burn Injuries
Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Nimbus Hydrogel - Product Status
Nimbus Hydrogel - Product Description
Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
Wound Dressing - Product Status
Wound Dressing - Product Description
Syracuse University Pipeline Products & Ongoing Clinical Trials Overview
Antimicrobial Hydrogel Web - Product Status
Antimicrobial Hydrogel Web - Product Description
Shape Memory Polymer Hydrogel - Product Status
Shape Memory Polymer Hydrogel - Product Description
Glossary
List of Figures
Antimicrobial Hydrogel Dressings - Pipeline Products by Stage of Development
Antimicrobial Hydrogel Dressings - Pipeline Products by Territory
Antimicrobial Hydrogel Dressings - Pipeline Products by Regulatory Path
Antimicrobial Hydrogel Dressings - Pipeline Products by Estimated Approval Date
Antimicrobial Hydrogel Dressings - Ongoing Clinical Trials
Companies Mentioned
- CelaCare Technologies LLC
- Edixomed Ltd
- Gel4Med Inc
- In2cure AB
- Institute of Nano Science and Technology
- Kane Biotech Inc
- Novyx Technologies LLC
- O2 Regentech LLC
- Plurogen Therapeutics Inc
- Quick-Med Technologies Inc
- Smith & Nephew Plc
- Syracuse University
Methodology
Our market research methodology is designed to provide the clients with comprehensive and accurate information
on various
industries and markets. It includes data collection, primary interviews, macro-economic factor analysis,
country-level data
analysis etc.
The data is gathered from a wide range of sources, including industry reports, government statistics, and
company financials.
This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary
interviews are conducted
with industry experts and key stakeholders to gather their insights and perspectives on the market. This
information is then
combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis
is also carried
out to understand the impact of external factors on the market. Finally, country-level data analysis is
performed to
understand the market dynamics in specific regions and countries.
Reportlinker's market research methodology is designed to provide clients with a clear understanding of the
market, its trends,
and its future potential.
Related Topics
Related Reports
-
Cardiac Valve Repair Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
-
Abdominal Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
-
Fragile X Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
+ See all
Related Reports
More Reports